Catch up on news and events from the medical aesthetic industry around the globe. Join the mailing list to get the latest updates, including free webinars, practice enhancement tips, educational resources, and more.
TORONTO, August 15, 2019 (PRNewswire) – Venus Concept Ltd. (“Venus Concept”), a privately-held global medical aesthetic technology leader, provided unaudited financial results for the second quarter and first six months of 2019.
SAN JOSE, Calif. and TORONTO, March 15, 2019 (GLOBE NEWSWIRE) -- Restoration Robotics, Inc. (“Restoration Robotics”) (NASDAQ: HAIR), a global leader in robotic hair restoration, and Venus Concept Ltd. (“Venus Concept”), a privately-held global aesthetic technology leader, announced today that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction.
Charlotte, NC, November 19, 2018 - NeoGraft®, an innovative global leader in precision FUE hair restoration technology, announces the launch of a new on-demand hair transplant technician scheduling app for their physician partners.
We are pleased to announce the launch of our new Advanced Connectivity Module (ACM) Revenue Share Program, powered by Venus Connect™ smart technology. Our new Revenue Share Program is a continuation of our commitment to offer industry partners access to cutting-edge aesthetic technology without the traditional barriers they may have encountered in the past.
Venus Concept Ltd., a privately-held and innovative global aesthetic technology leader, is pleased to announce that is has entered into agreement to acquire NeoGraft Solutions' hair restoration business ("NeoGraft").
For more information call: (888) 907-0115 // firstname.lastname@example.org // 1880 N Commerce Parkway, Suite 2, Weston, FL, 33326 United States
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is cleared by the FDA for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less. The (MP)2 applicator is cleared for temporary reduction in the appearance of cellulite.
Venus Versa™ is cleared by the FDA for the treatment of benign pigmented epidermal and cutaneous lesions, benign cutaneous vascular lesions, removal of unwanted hair, treatment of acne vulgaris, dermatological procedures requiring ablation and resurfacing of the skin, and non-invasive treatment of moderate to severe wrinkles and rhytides.
NeoGraft® is a manual surgical instrument intended to be used in various general surgical procedures, including the minimally invasive FUE hair restoration procedure, and listed by the FDA as a Class I device. Venus Concept is the exclusive distributor for NeoGraft® in the U.S.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides and temporary reduction in the appearance of cellulite.
Venus Velocity™ is cleared by the FDA for hair removal, permanent hair reduction, and the treatment of pseudofolliculitis barbae.
Venus Viva™ is cleared by the FDA for dermatological procedures requiring ablation and resurfacing of the skin.
Venus Freeze Plus™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides.
Venus Heal™ is cleared by the FDA for the relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation. The treatment of these conditions will lead to the treatment of certain soft tissue injuries and conditions.
Venus Glow™ is listed by the FDA as a Class I device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.